Etrolizumab [1044758-60-2]

TargetMol Chemicals

Etrolizumab

9

1044758-60-2

Antibody

Research Use Only

Etrolizumab

Etrolizumab (rhuMAb Beta7), a gut-selective anti-beta7 integrin monoclonal antibody, targets the beta7 subunit of alpha4beta7 and alphaEbeta7 integrins specifically, demonstrating affinity with K i values of 18 nM for Human alpha4beta7 and 1800 pM for Human alphaEbeta7-293. It is utilized in the research of inflammatory bowel disease (IBD) [1] [2].

3 years

-20°C

12352203